Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Latent HSV 1 virus in trigeminal ganglia: the optimal site for linking prevention of Alzheimer's disease to vaccination.

Ball MJ, Mathews R, Steiner I, Hill JM, Wisner TW, Murdoch GH, Kohama S, Sexton G, Nagalla S.

Neurobiol Aging. 2001 Sep-Oct;22(5):705-9; discussion 717-9. Review. No abstract available.

PMID:
11705627
2.

Potential for HSV-1 vaccination to reduce risk of HSV-1 encephalitis and/or Alzheimer's disease?

Esiri MM.

Neurobiol Aging. 2001 Sep-Oct;22(5):711-3; discussion 717-9. Review. No abstract available.

PMID:
11705628
3.

Vaccination prevents latent HSV1 infection of mouse brain.

Lin WR, Jennings R, Smith TL, Wozniak MA, Itzhaki RF.

Neurobiol Aging. 2001 Sep-Oct;22(5):699-703.

PMID:
11705626
4.

Alzheimer's disease and herpes.

Itzhaki RF, Dobson CB.

CMAJ. 2002 Jul 9;167(1):13. No abstract available.

5.

Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients.

Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF.

J Med Virol. 2005 Feb;75(2):300-6.

PMID:
15602731
6.

Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion.

Kramer M, Riley J, Spoering A, Coen D, Knipe D.

Curr Eye Res. 2003 Mar-Apr;26(3-4):185-94.

PMID:
12815546
7.

Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.

Wozniak MA, Mee AP, Itzhaki RF.

J Pathol. 2009 Jan;217(1):131-8. doi: 10.1002/path.2449.

PMID:
18973185
9.

Potential prophylactic and therapeutic vaccines for HSV infections.

Ramachandran S, Kinchington PR.

Curr Pharm Des. 2007;13(19):1965-73. Review.

PMID:
17627530
10.

Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?

Itzhaki RF, Wozniak MA.

Alzheimers Dement. 2010 Jan;6(1):83-4; author reply 85. doi: 10.1016/j.jalz.2009.07.136. No abstract available.

PMID:
20129323
11.
12.

Apolipoprotein E genotype influences vertical transmission of herpes simplex virus type 1 in a gender specific manner.

Burgos JS, Ramirez C, Sastre I, Valdivieso F.

Aging Cell. 2007 Dec;6(6):841-2. Epub 2007 Aug 24.

13.

[Herpes simplex virus type 1 as risk factor associated to Alzheimer disease].

Martin C, SolĂ­s L, Concha MI, Otth C.

Rev Med Chil. 2011 Jun;139(6):779-86. doi: /S0034-98872011000600013. Epub 2011 Sep 14. Review. Spanish.

14.

HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2.

Mori I, Liu B, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y.

Microbes Infect. 2005 Dec;7(15):1492-500. Epub 2005 Jul 1.

PMID:
16054416
15.

The essential lesion of Alzheimer disease: a surprise in retrospect.

Ball MJ.

J Alzheimers Dis. 2006;9(3 Suppl):29-33. Review.

PMID:
16914842
16.

Vaccines for herpes simplex virus infections.

Koelle DM.

Curr Opin Investig Drugs. 2006 Feb;7(2):136-41. Review.

PMID:
16499283
17.

An infectious conspiracy: the case for HSV-1 and APOEepsilon4 in Alzheimer's disease.

Federoff HJ.

Neurobiol Aging. 1999 Jul-Aug;20(4):467-8. Review. No abstract available.

PMID:
10604442
18.

Immunobiology of herpes simplex virus (HSV) infections.

Corey L.

Herpes. 2001 Mar;8 Suppl 1:1A. No abstract available.

PMID:
11867026
19.

Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease.

Mori I, Kimura Y, Naiki H, Matsubara R, Takeuchi T, Yokochi T, Nishiyama Y.

J Med Virol. 2004 Aug;73(4):605-11.

PMID:
15221907
20.

Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease.

Itzhaki R.

Herpes. 2004 Jun;11 Suppl 2:77A-82A. Review.

PMID:
15319093
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk